Free CME from PeerView


Oncology CME

Credits: 1.25 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Changing the Game for Patients With ES-SCLC Through Multidisciplinary Collaboration: Best Practices to Optimize Immunotherapy-Based Approaches and Improve Patient Outcomes
Stephen V. Liu, MD
February 12, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A New Dawn in the Therapeutic Management of Biliary Cancers: Integrating Precision Medicine With New and Emerging Targeted Strategies
Milind Javle, MD
February 11, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat: Remodeling the HCC Treatment Algorithm With New and Emerging Monotherapy, Combination, and Multimodal Approaches
Richard S. Finn, MD
February 9, 2021
Credits: 1.75 CME / MOC
Medical Learning Institute, Inc.
Taking Aim at GI Cancers: New Opportunities to Deliver Personalized Treatment With HER2 and Other Molecularly Targeted Therapies
Axel Grothey, MD
February 8, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Checkpoint Inhibition in Gastrointestinal Cancers: Recent Advances in Gastric, Esophageal, and Colorectal Cancers and Their Application in Clinical Practice
Manish A. Shah, MD, FASCO
February 3, 2021
Credits: 0.75 CME
Medical Learning Institute, Inc.
Selective Inhibition of Oncogenic Transcription and Other Novel Approaches in the Treatment of Small Cell Lung Cancer: An Illustrative Guide to Navigating the Evolving Treatment Landscape and Integrating Latest Treatment Modalities Into Clinical Care
Jacob Sands, MD
January 29, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing in the Context of an Expanding Treatment Landscape
Maria Arcila, MD
January 26, 2021
Credits: 0.70 CME
Purdue University
Changing the Treatment Story With Hormonal Therapy in Prostate Cancer: Challenges and Opportunities for Improving Care Across Disease Settings
Neal D. Shore, MD, FACS
December 30, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
Marcia S. Brose, MD, PhD
December 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting Ocular Toxicity in Multiple Myeloma: Opportunities for Ophthalmology-Oncology Collaboration
Sagar Lonial, MD, FACP
December 29, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Rethinking Glioblastoma Care in an Evolving Therapeutic Landscape: Expert Perspectives on Modern Modalities, Novel Agents, and Combinations
Steven Brem, MD
December 29, 2020
Credits: 1.50 CME
Penn State College of Medicine
How I Think, How I Treat in the New Age of AML Care: Personal Perspectives on New Evidence and Innovative Therapeutics
Tara Lin, MD
December 24, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Rewriting Patient Care in Mantle Cell Lymphoma: How Innovative Therapy Is Poised to Challenge Conventional Treatment
Ian W. Flinn, MD, PhD
December 24, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Exploring Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management
Professor David I. Marks, MB, MS, FRACP, PhD, FRCPath
December 24, 2020
Credits: 1.50 CME
Penn State College of Medicine
Building New Management Models for NHL Care: Tumor Board Insights on Innovative Therapeutics in FL and DLBCL
Nathan H. Fowler, MD
December 23, 2020
Credits: 1.50 CME
Penn State College of Medicine
Mapping the New Era in CLL Management: Precision Medicine and Patient Perspectives in Treatment-Naïve and Relapsed Disease
John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci
December 23, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
Understanding the Evolving Treatment Landscape in Prostate Cancer: How to Leverage the Latest Advances and Strategies to Optimize Patient Outcomes
William K. Oh, MD
December 22, 2020
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach
Bruce R. Korf, MD, PhD
December 18, 2020
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Personalizing and Prolonging Care in GIST: Expert Guidance on Integrating New TKI Strategies
Margaret von Mehren, MD
December 8, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
The Case for Challenging Conventional Care in Tenosynovial Giant Cell Tumor: Insights on Integrating Targeted Therapy Into Multimodal Management
William D. Tap, MD
December 7, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Unraveling the Intricacies of HCC Management With Your Multidisciplinary Team: A Closer Look at Effective Selection and Sequencing Strategies in an Expanding Treatment Landscape
Amit Singal, MD, MS
December 1, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Molecular Testing and Targeted Therapies in NSCLC: Essential Guidance for Modern Patient-Centered Precision Lung Cancer Care
Suresh S. Ramalingam, MD, FACP, FASCO
November 30, 2020
Credits: 1.00 CME
PeerView Institute
How I Think, How I Treat: Individualizing RCC Therapy in the Era of Immuno-Oncology
David F. McDermott, MD
November 20, 2020
Credits: 1.00 CME / MOC
PeerView Institute
Solutions for Tenosynovial Giant Cell Tumors: Employing Effective Multimodal and Multidisciplinary Approaches to Patient Care
Robin L. Jones, MD
November 20, 2020
Credits: 1.50 CME / MOC / CNE
PeerView Institute
Emergency Department on Alert: Solving Oncologic Emergency Quandaries During the Immuno-Oncology Era and COVID-19 Pandemic
Jarushka Naidoo, MB, BCH, MHS / Andrew Stolbach, MD, MPH
November 20, 2020
Credits: 1.00 CME
PeerView Institute
Modernizing Your Radiation Oncology Practice With Tumor Treating Fields and Other Novel Multimodal Strategies: Understanding the Science, Evidence, and Practical Aspects Across a Range of Solid Tumors
Hani M. Babiker, MD
November 12, 2020
Credits: 1.50 CME / MOC / CNE / CPE
PeerView Institute
Immunotherapy in the Treatment Arsenal for Small Cell Lung Cancer, and Managed Care Implications for the Four Ps: Patient, Provider, Pharmacy, and Plan
Stephen V. Liu, MD
Bhavesh Shah, RPh, BCOP
November 12, 2020
Credits: 1.00 CME
PeerView Institute
Preparing for the Next Leap Forward in Multimodal Management of Esophageal/GEJ Cancer: An Interdisciplinary Tumor Board on Adjuvant Immunotherapy
Ronan J. Kelly, MD, MBA
November 11, 2020
Credits: 1.00 CME
PeerView Institute
Turning Tides in Targeted Therapy for Early-Stage EGFR-Mutated NSCLC: Latest Data and Practical Guidance for Thoracic Surgeons and the Multidisciplinary Team on the Emerging Role of EGFR-Targeted Therapy in Resectable Lung Cancer
David R. Jones, MD
November 11, 2020
Credits: 1.50 CME / MOC / CNE / CPE
PeerView Institute
Managed Care Implications of the Expanding Role of PARP Inhibitors in Oncology: Evolving Evidence Base, Current Value Assessment Frameworks, and Considerations for Decision-Making in Managed Care Settings
Kathleen N. Moore, MD, MS / Kristi Jhangiani, PharmD, BCPS
November 6, 2020

Pages

Upcoming Live Events

Education Collections


Recent CME Podcast

More Podcasts from PeerView